TY  - JOUR
T1  - Malignite ilişkili vena kava superior sendromunun tedavisinde stent uygulanmasının etkinliği: tek merkez deneyimi
TT  - Efficiency of endovascular stenting in the treatment of malignancy related vena cava superior syndrome: single center experience
AU  - Beşen, Ali Ayberk
PY  - 2018
DA  - December
DO  - 10.21601/ortadogutipdergisi.457666
JF  - Ortadoğu Tıp Dergisi
JO  - omj
PB  - MEDİTAGEM Ltd. Şti.
WT  - DergiPark
SN  - 2548-0251
SP  - 449
EP  - 453
VL  - 10
IS  - 4
LA  - tr
AB  - Amaç: Malignite ilişkilivena kava superior (VKS) sendromunun semptomatik tedavisinde endovasküler stentuygulanan hastalarda bu yaklaşımın etkinliğini değerlendirmeyi amaçladık. Gereç ve Yöntem: Malign VKS sendromunedeniyle Başkent Üniversitesinde Aralık 2005- Ekim 2016 tarihleri arasındaendovasküler stent uygulanan 35 hasta retrospektif olarak incelenmiştir. Bulgular: 35 hastaya toplam 54stent işlemi gerçekleştirilmiştir.Hastaların %48’ine tek stent %43’üne ise iki stent konulmuştur. Stent uygulananhastaların 6’sı kadın 29’u ise erkekti. Tüm hastaların %68’ini evre 4, %77’sini akciğerkanserli hastalar oluşturmuştur. İşlem sonrası 31 (%89) hastada semptomatikrahatlama gözlenmiştir. Hastaların takibinde 4 hastada stent trombozu 2 hastadaise tümör basısı nedeni ile re-stent ihtiyacı olmuştur. Stent sonrası 23hastaya anti-koagülan tedavi verilmiştir. Tüm grupta ortanca genel sağkalım(GSK) 20 hafta (aralık 6,5-33,4 ) olarak bulunmuştur. Stent sonrası akciğerkanserli hastalarda GSK diğer gruplara göre sayısal olarak daha kısa olarakbulunmuş ancak istatistiksel anlamlılığa ulaşmamıştır. Sonuç: Malignite ilişkili SVKsendromunun palyatif tedavisinde endovasküler stent uygulanması tanı anında yada progresif hastalık durumunda yüksek klinik başarı ve düşük morbidite ileetkin bir tedavi yöntemidir.
KW  - Vena kava superior sendromu
KW  - stent
KW  - akciğer kanseri
N2  - Aim: Toevaluate efficacy of the endovascular stenting for symptomatic treatment ofmalignancy-related vena cava superior (VCS) syndrome.Material and Method: Thirty-fivepatients who underwent endovascular stenting at Baskent University betweenDecember 2005 and October 2016 due to malign VCS were evaluated retrospectively.Results: Atotal of 54 stenting procedures were performed in 35 patients. 48% of thepatients had a single stent and 43% had two stents. Of the patients onstenting, 6 were women and 29 were men. 68% of all patients were stage 4, and77% were patients with lung cancer. Symptomatic relief was observed in 31 (89%)patients after the procedure. Re-stenting was performed in four patients forstent thrombosis and in two patients for tumor ingrowth. After stenting, 23 patientswere given anti-coagulant treatment. Median overall survival (OS) was 20 weeks(range, 6.5-33.4) in the whole group. In patients with lung cancer, OS afterstenting was found to be numerically shorter than other groups, but it did notreach statistical significance.Conclusion: Endovascular stenting in the palliative treatment ofmalignancy-related SVC syndrome is an effective treatment method with highclinical success and low morbidity both in newly diagnosed patients and inpatients on progression.
CR  - 1.	Cheng S. Superior vena cava syndrome: a contemporary review of a historic disease. Cardiol Rev, 2009; 17(1): p. 16-23.
CR  - 2.	Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006; 85:37.
CR  - 3.	Armstrong BA, Perez CA, Simpson JR, Hederman MA. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987; 13:531.
CR  - 4.	Wilson, L.D., F.C. Detterbeck, and J. Yahalom. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med, 2007; 356(18): p. 1862-9.
CR  - 5.	Dombernowsky P, Hansen HH. Combination chemotherapy in the management of superior vena caval obstruction in small-cell anaplastic carcinoma of the lung. Acta Med Scand 1978; 204:513.
CR  - 6.	Kvale PA, Selecky PA, Prakash UB. American College of Chest Physicians. Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132:368S.
CR  - 7.	Dondelinger RF, Goffette P, Kurdziel JC, Roche A. Expandable metal stents for stenoses of the ve- nae cavae and large veins. Semin Intervent Radiol 1991; 8:252–263.
CR  - 8.	Wurschmidt F, Bunemann H, Heilmann HP. Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases. Int J Radiat Oncol Biol Phys 1995; 33:77–82.
CR  - 9.	Urban T, Lebeau B, Chastang C, et al. Superior vena cava syndrome in small cell lung cancer. Arch Intern Med 1993; 153:384–387
CR  - 10.	Charnsangavej C, Carrasco CH, Wallace S,  et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology, 1986; 161(2): p. 295-8.
CR  - 11.	Gauden, S.J., Superior vena cava syndrome induced by bronchogenic carcinoma: is this an oncological emergency? Australas Radiol, 1993; 37(4): p. 363-6.
CR  - 12.	Schraufnagel DE, Hill R, Leech JA, Pare JA. Superior vena caval obstruction. Is it a medical emergency? Am J Med, 1981; 70(6): p. 1169-74.
CR  - 13.	Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 2006; 29:319.
CR  - 14.	Oudkerk M, Kuijpers TJ, Schmitz PI, et al. Self-expanding metal stents for palliative treatment of superior vena caval syndrome. Cardiovasc Intervent Radiol 1996; 19:146.
CR  - 15.	Nagata T, Makutani S, Uchida H, et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol 2007; 30:959.
CR  - 16.	Lanciego C, Chacón JL, Julián A, et al. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol 2001; 177:585.
CR  - 17.	Martins SJ, Pereira JR. Clinical factors and prognosis in non-small cell lung cancer. Am J Clin Oncol 1999; 22:453.
UR  - https://doi.org/10.21601/ortadogutipdergisi.457666
L1  - https://dergipark.org.tr/en/download/article-file/584382
ER  -